AI
SYNH

Axiom Investors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Axiom Investors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-77,296
Closed -$4.07M – 162
2016
Q4 		$4.07M Buy
77,296
+61,447
+388% +$2.97M 0.12% 88
2016
Q3 		$707K Sell
15,849
-29,543
-65% -$1.28M 0.02% 139
2016
Q2 		$1.73M Sell
45,392
-33,986
-43% -$1.49M 0.05% 116
2016
Q1 		$3.27M Buy
79,378
+39,069
+97% +$1.61M 0.1% 85
2015
Q4 		$1.96M Buy
+40,309
New +$1.79M 0.06% 107

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Axiom Investors's SYNH Position: Q1 2017 in Review

Axiom Investors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2017, closing a stake of 77,296 shares — an estimated $4.07M sold.

Axiom Investors first reported a position in SYNH in Q4 2015 and held it in 5 quarters. The position peaked at $4.07M in Q4 2016. 232 funds tracked by Wall St. Rank hold SYNH as of Q1 2017.

  • Axiom Investors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2017 after selling out during the quarter.
  • Axiom Investors sold 77,296 Syneos Health, Inc. Class A Common Stock shares in Q1 2017, an estimated $4.07M.
  • Axiom Investors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 5 quarters.
  • Axiom Investors's Syneos Health, Inc. Class A Common Stock position peaked at $4.07M in Q4 2016.
  • 232 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2017.

Based on Axiom Investors's 13F filing for Q1 2017, filed 12 May 2017.